Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation
- PMID: 28960644
- DOI: 10.1111/pin.12587
Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation
Abstract
Succinate dehydrogenase-deficient renal cell carcinoma (SDH-deficient RCC) is a newly introduced histological type of RCC, which is caused by loss of subunit genes of SDH. It is known to frequently demonstrate familial occurrence and be frequently associated with gastrointestinal stromal tumors and paraganglioma. To date, only 53 cases have been reported. Here, we present an additional case of SDH-deficient RCC occurring in a 40-year-old female. The tumor was histologically biphasic, consisting of tubular and solid architectures. The tumor cells possessed oval nuclei with small nucleoli, and an eosinophilic granular cytoplasm with occasional vacuoles. These cells completely lost the immunohistochemical expression of B subunit of SDH (SDHB). Consequently, the tumor was diagnosed as SDHB-deficient RCC. We identified a novel germ line mutation of the SDHB gene, and also confirmed a hemizygous deletion of the wild-type allele in the tumor cells. To define the pathological characteristics of SDH-deficient RCC, precise diagnosis and accumulation of more cases are required.
Keywords: SDH A and B subunits (SDHA and SDHB); germline mutations; kidney; renal cell carcinoma (RCC); succinate dehydrogenase (SDH).
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.
Similar articles
-
Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.Pol J Pathol. 2016 Mar;67(1):3-7. doi: 10.5114/pjp.2016.59227. Pol J Pathol. 2016. PMID: 27179267 Review.
-
[Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].Pathologe. 2016 Mar;37(2):144-52. doi: 10.1007/s00292-016-0158-8. Pathologe. 2016. PMID: 26979428 German.
-
Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma.Pathol Res Pract. 2024 Sep;261:155459. doi: 10.1016/j.prp.2024.155459. Epub 2024 Jul 17. Pathol Res Pract. 2024. PMID: 39083879
-
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.Mod Pathol. 2015 Jan;28(1):80-94. doi: 10.1038/modpathol.2014.86. Epub 2014 Jul 18. Mod Pathol. 2015. PMID: 25034258
-
Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.Arch Pathol Lab Med. 2018 Oct;142(10):1284-1288. doi: 10.5858/arpa.2017-0199-RS. Arch Pathol Lab Med. 2018. PMID: 30281364 Review.
Cited by
-
MicroRNA-96: A therapeutic and diagnostic tumor marker.Iran J Basic Med Sci. 2022 Jan;25(1):3-13. doi: 10.22038/IJBMS.2021.59604.13226. Iran J Basic Med Sci. 2022. PMID: 35656454 Free PMC article. Review.
-
MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB.Cancer Cell Int. 2019 Nov 12;19:287. doi: 10.1186/s12935-019-1003-y. eCollection 2019. Cancer Cell Int. 2019. PMID: 31749660 Free PMC article.
-
Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes.Cancers (Basel). 2020 Jan 3;12(1):124. doi: 10.3390/cancers12010124. Cancers (Basel). 2020. PMID: 31947710 Free PMC article. Review.
-
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.Biomark Res. 2022 Jun 4;10(1):40. doi: 10.1186/s40364-022-00382-4. Biomark Res. 2022. PMID: 35659780 Free PMC article. Review.
-
Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.Oncologist. 2021 Sep;26(9):e1652-e1655. doi: 10.1002/onco.13825. Epub 2021 Jun 1. Oncologist. 2021. PMID: 34003534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous